E-resources
-
Amano, Koji, MD; Maeda, Isseki, MD, PhD; Morita, Tatsuya, MD; Miura, Tomofumi, MD; Inoue, Satoshi, MD; Ikenaga, Masayuki, MD; Matsumoto, Yoshihisa, MD, PhD; Baba, Mika, MD; Sekine, Ryuichi, MD; Yamaguchi, Takashi, MD, PhD; Hirohashi, Takeshi, MD; Tajima, Tsukasa, MD; Tatara, Ryohei, MD; Watanabe, Hiroaki, MD; Otani, Hiroyuki, MD; Takigawa, Chizuko, MD; Matsuda, Yoshinobu, MD; Nagaoka, Hiroka, MD; Mori, Masanori, MD; Kinoshita, Hiroya, MD
Journal of pain and symptom management, 05/2016, Volume: 51, Issue: 5Journal Article
Abstract Context Plasma C-reactive protein (CRP) levels are elevated in patients with advanced cancer. Objectives To investigate CRP as a prognostic marker in palliative settings. Methods This multicenter prospective cohort study comprised 2426 patients. Laboratory data were obtained at baseline, and all patients were followed until death or six months after their enrollment. A total of 1511 patients were eligible for the analyses. They were divided into four groups: low-CRP (CRP < 1 mg/dL), moderate-CRP (1 ≤ CRP <5 mg/dL), high-CRP (5 ≤ CRP <10 mg/dL), and very high-CRP (10 mg/dL ≤ CRP) groups. Survival was investigated by the Kaplan-Meier method with the log-rank test. The 30-, 60-, and 90-day mortality rates were tested by Chi-squared tests. Univariate- and multivariate-adjusted hazard ratios (HRs) and 95% CIs in each group were calculated using Cox proportional hazard models. Results Survival rate decreased and mortality rate increased with increasing CRP level. The differences in survival and 30-, 60-, and 90-day mortality rates among the groups were statistically significant ( P < 0.001). Baseline CRP level was significantly associated with a higher risk of mortality after adjustment for age, gender, primary tumor site, metastasis, chemotherapy, Eastern Cooperative Oncology Group Performance Status, and setting of care (moderate-CRP: HR 1.47 95% CI 1.24–1.73, high-CRP: HR 2.09 95% CI 1.74–2.50, and very high-CRP: HR 2.55 95% CI 2.13–3.05 vs. low-CRP). Conclusion Clear dose-effect relationships between elevated CRP levels and prognoses indicate that CRP could be useful in predicting prognoses in patients with advanced cancer.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.